• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GnRH类似物联合低剂量激素替代疗法对子宫内膜异位症女性的内分泌影响。

Endocrine effects of GnRH analogue with low-dose hormone replacement therapy in women with endometriosis.

作者信息

Howell R, Dowsett M, King N, Edmonds D K

机构信息

Department of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, London, UK.

出版信息

Clin Endocrinol (Oxf). 1995 Nov;43(5):609-15. doi: 10.1111/j.1365-2265.1995.tb02926.x.

DOI:10.1111/j.1365-2265.1995.tb02926.x
PMID:8548946
Abstract

OBJECTIVE

GnRH analogues are being used increasingly for a number of oestrogen dependent conditions in women. The resultant profound hypo-oestrogenism is a disadvantage, however, but the preservation of pituitary sensitivity to negative feedback by oestradiol is not well defined. We have determined the effect on gonadotrophins and inhibin of GnRH analogue plus low-dose continuous combined hormone replacement therapy in comparison with GnRH analogue therapy alone.

DESIGN

Randomized controlled trial.

PATIENTS

Fifty premenopausal women with endometriosis randomized to treatment with goserelin alone (Group 1) or goserelin plus 17 beta-oestradiol and medroxyprogesterone acetate (Group 2).

MEASUREMENTS

FSH, LH, oestradiol, oestrone, inhibin before and during treatment.

RESULTS

Oestradiol and oestrone were suppressed in both groups, but Group 2 had significantly higher oestradiol during the hormone replacement therapy period. LH was suppressed in both groups. In Group 1, FSH levels recovered during treatment but, in contrast, in Group 2, FSH levels remained suppressed throughout treatment. Inhibin was significantly lower in Group 2, but not in Group 1, during treatment compared to pretreatment.

CONCLUSIONS

Pituitary secretion of FSH appears to remain responsive to feedback control by oestradiol during GnRH analogue therapy and is incompletely suppressed, unlike LH which remains completely suppressed. The possible mechanisms for this are discussed.

摘要

目的

促性腺激素释放激素(GnRH)类似物越来越多地用于治疗女性多种雌激素依赖型疾病。然而,由此导致的严重低雌激素状态是一个不利因素,而且垂体对雌二醇负反馈的敏感性保留情况尚不明确。我们已确定GnRH类似物联合低剂量连续联合激素替代疗法与单独使用GnRH类似物疗法相比,对促性腺激素和抑制素的影响。

设计

随机对照试验。

患者

50名患有子宫内膜异位症的绝经前女性,随机分为单独使用戈舍瑞林治疗组(第1组)或戈舍瑞林联合17β - 雌二醇和醋酸甲羟孕酮治疗组(第2组)。

测量指标

治疗前及治疗期间的促卵泡生成素(FSH)、促黄体生成素(LH)、雌二醇、雌酮、抑制素。

结果

两组的雌二醇和雌酮均受到抑制,但在激素替代治疗期间,第2组的雌二醇水平显著更高。两组的LH均受到抑制。在第1组中,FSH水平在治疗期间有所恢复,而相比之下,在第2组中,FSH水平在整个治疗过程中一直受到抑制。与治疗前相比,治疗期间第2组的抑制素显著降低,但第1组未降低。

结论

在GnRH类似物治疗期间,垂体FSH的分泌似乎仍对雌二醇的反馈控制有反应,且未被完全抑制,这与完全被抑制的LH不同。文中讨论了其可能的机制。

相似文献

1
Endocrine effects of GnRH analogue with low-dose hormone replacement therapy in women with endometriosis.GnRH类似物联合低剂量激素替代疗法对子宫内膜异位症女性的内分泌影响。
Clin Endocrinol (Oxf). 1995 Nov;43(5):609-15. doi: 10.1111/j.1365-2265.1995.tb02926.x.
2
Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.促性腺激素释放激素类似物(戈舍瑞林)加激素替代疗法治疗子宫内膜异位症:一项随机对照试验
Fertil Steril. 1995 Sep;64(3):474-81. doi: 10.1016/s0015-0282(16)57779-6.
3
[Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis].促性腺激素释放激素激动剂联合雌二醇贴片及口服醋酸甲羟孕酮治疗子宫内膜异位症的疗效及安全性
Zhonghua Fu Chan Ke Za Zhi. 2009 Jul;44(7):504-8.
4
Add-back therapy in the treatment of endometriosis: the European experience.子宫内膜异位症治疗中的补充疗法:欧洲经验
Br J Obstet Gynaecol. 1996 Oct;103 Suppl 14:10-3.
5
Effect of chronic exposure to a gonadotrophin-releasing hormone agonist on in vitro responsiveness of ovine pituitary cells to inhibin, activin and oestradiol.长期暴露于促性腺激素释放激素激动剂对绵羊垂体细胞体外对抑制素、激活素和雌二醇反应性的影响。
J Endocrinol. 1994 Mar;140(3):483-93. doi: 10.1677/joe.0.1400483.
6
The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis.达那唑和促黄体生成素释放激素(LHRH)激动剂类似物戈舍瑞林(诺雷德)对子宫内膜异位症女性促黄体生成素生物活性的影响。
Clin Endocrinol (Oxf). 1990 Oct;33(4):539-46. doi: 10.1111/j.1365-2265.1990.tb03891.x.
7
Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.醋酸戈舍瑞林单一促性腺激素释放激素激动剂与戈舍瑞林联合雌激素-孕激素反向添加疗法治疗子宫内膜异位症的比较。
Fertil Steril. 1995 Nov;64(5):903-8. doi: 10.1016/s0015-0282(16)57900-x.
8
Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).使用尿促性素(Metrodin)或重组促卵泡生成素(Puregon)进行控制性卵巢过度刺激后的雌二醇和免疫反应性抑制素样分泌模式。
Hum Reprod. 1996 May;11(5):962-7. doi: 10.1093/oxfordjournals.humrep.a019332.
9
[Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis].促性腺激素释放激素激动剂联合雌二醇屈螺酮治疗子宫内膜异位症的临床疗效及安全性
Zhonghua Fu Chan Ke Za Zhi. 2010 Apr;45(4):247-51.
10
Serum inhibin during lactation: relation to the gonadotrophins and gonadal steroids.哺乳期血清抑制素:与促性腺激素及性腺类固醇的关系。
Clin Endocrinol (Oxf). 1994 Dec;41(6):771-7. doi: 10.1111/j.1365-2265.1994.tb02792.x.

引用本文的文献

1
Prospects for potential therapy targeting immune‑associated factors in endometriosis (Review).针对子宫内膜异位症中免疫相关因子的潜在治疗前景(综述)
Mol Med Rep. 2025 Mar;31(3). doi: 10.3892/mmr.2024.13422. Epub 2024 Dec 24.